Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN
8219cov1a.jpg

May 10, 2004 Cover

Volume 82, Issue 19

'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs

Credit:

Full Article
Volume 82 | Issue 19

All Issues

Pharmaceuticals

Biopharmaceuticals

'Big pharma' is weaving biotech into its research regime, developing multiple therapeutic indications for protein drugs

  • Alan Cowley Has Long Been a 'Main' Player

  • Joseph A. Miller Jr.

    Corning's chief technology officer chose new challenges over retirement to academia

  • Reach across the Pond

    U.S., EU share views on regulation at trans-Atlantic conference on chemicals

ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT